Healthcare Technology Report July 20, 2022

American biotechs strapped for cash apparently have a rough road ahead. GlobalData reports that, compared to a year ago, venture financing deal value for U.S. biotechs...

Today's Sponsors

Oliver Wyman
Upfront Healthcare

Today's Sponsors


Today's Sponsor


Topics: Biotechnology, Investments, Pharma / Biotech, Trends
How to navigate the biotech investment downturn: Get back to basics
Investment fuels AI-driven development of breakthrough genomic medicines
Biotech IPO market slowdown continues as third quarter is weakest since 2011
Listen: Pharma’s telehealth gold mine, the return of the biotech IPO, & a merger deferred
Can biotech IPOs bounce back? Third Harmonic to test investor appetite with planned offering